Form 4 SYNOPSYS INC For: Dec 08 Filed by: Kankanwadi Sudhindra
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Mizuho on Synopsys (SNPS): 'FQ4 Better than Feared; FY26 Guidance Bracketing Consensus a Big Relief'
December 10, 2025 4:45 PM ESTMizuho on Synopsys (NASDAQ: SNPS): 'FQ4 Better than Feared; FY26 Guidance Bracketing Consensus a Big Relief'.
The analyst comments "Our Take: Rev slightly above and nice EPS beat expectations. 4Q25 Rev/EPS of $2.255B/$2.90 vs. $2.253B/$2.79 cons. FY26 guided to $9.61/$14.36 midpoint excluding $0.11B from divestitures... More
Goldman Sachs on Synopsys (SNPS): 'We expect the stock to move higher'
December 10, 2025 4:43 PM ESTGoldman Sachs analyst James Schneider reiterated a Buy rating and $560.00 price target on Synopsys (NASDAQ: SNPS).
The analyst comments "Key stock takeaways: We expect the stock to move higher following a modestly better quarter with mixed FY2026 guidance that was just below the Street on revenue but well above on EPS. We believe investors were expecting potentially softer guidance following Synopsys' recent guide down as a result of disruptions in its China business (stemming from the temporary EDA ban) and revenue at a large foundry customer not materializing. As a... More
